Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Lantern Pharma Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 26 | 1 | 26 | +1 |
| Shares | 1.42M | 2.47K | 1.44M | +21.4K (+1.5%) |
| Value | $8.06M | $14.0K | $6.84M | −$1.21M (−15.0%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Lantern Pharma Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 14,558 | $70.0K | 0.00% |
| Citadel Advisors LLC | 12,753 | $61.0K | 0.00% |
| Bogart Wealth, LLC | 75 | $0 | 0.00% |
Sold out (2)
Institutions that held Lantern Pharma Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Spire Wealth Management | 2,025 | $12.0K |
| GHP Investment Advisors, Inc. | 300 | $2.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Lantern Pharma Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Urban Wealth Management, LLC | 2,472 | $14.0K |